NCT02673138 Effect of Canagliflozin in T1DM (Type 1 Diabetes Melitus) After Interruption of Continuous Subcutaneous Insulin Infusion Status COMPLETED Phase NA
NCT02660827 Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes Status COMPLETED Phase NA
NCT02651181 Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes The DREAMED Trail Status COMPLETED Phase NA
NCT02646878 A Feasibility Study to Evaluate the Performance of the Harmony 1 Sensors in Adults and Pediatrics Status WITHDRAWN Phase NA
NCT02641522 Modulation of STAT3 Signaling With Siltuximab in Type 1 Diabetes Status COMPLETED Phase EARLY_PHASE1
NCT02636491 Use of an Automated Insulin Delivery System Compared to Sensor Augmented Pump at Patients With Type 1 Diabetes (T1D) Status COMPLETED Phase NA
NCT02632032 Impact of a Diabetes Camp on Glycemic Control Among Children and Adolescents Living With Type 1 Diabetes in Cameroon Status COMPLETED Phase NA
NCT02631265 Insulin-based Strategies to Prevent Hypoglycemia During Exercise Status COMPLETED Phase NA
NCT02626936 Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation Status COMPLETED Phase PHASE2
NCT02620332 Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De) Status COMPLETED Phase PHASE1
NCT02617654 Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes Status COMPLETED Phase PHASE2
NCT02617160 Evaluation of Automated Insulin Pump Settings Using the Advisor Pro (Previously Called) MD-Logic Pump Advisor-three Segments Study Status TERMINATED Phase NA
NCT02611232 Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults Status UNKNOWN Phase PHASE2